Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Yeh

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Clinical Immunology (Orlando, Fla.)|April 29, 1999
Effects of immune complex formation and complement activation on circulating platelets in the primateD J Birmingham, L A Hebert, X P Shen, et al.
Transplantation|June 27, 2000
A recombinant soluble chimeric complement inhibitor composed of human CD46 and CD55 reduces acute cardiac tissue injury in models of pig-to-human heart transplantationT J Kroshus, C T Salerno, C G Yeh, et al.
Ophthalmology. Retina|May 4, 2019
Cost Savings Analysis for a Diabetic Retinopathy Teleretinal Screening Program Using an Activity-Based Costing ApproachRobert B Garoon, Weijie V Lin, Alex K Young, et al.
Transplantation|November 11, 1991
The effect of soluble complement receptor type 1 on hyperacute xenograft rejectionS K Pruitt, W M Baldwin, H C Marsh, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1995
The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritisW G Couser, R J Johnson, B A Young, et al.
Pharmacological Research|September 1, 2001
Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitorC Qian, S B Hwang, L Libertine-Garahan, et al.
Drug and Alcohol Dependence|August 26, 2022
Kratom use categories and their associations with co-occurring substance use and mental health disorder symptoms during the COVID-19 pandemicDavid Adzrago, Elizabeth O Obekpa, Tiffany A Suragh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1992
Role of complement in endotoxin/platelet-activating factor-induced lung injuryR Rabinovici, C G Yeh, L M Hillegass, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2024
Healthcare Costs in the United States by Demographic Characteristics and Comorbidity StatusNaomi N Adjei, Allen Haas, Charlotte C Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1992
Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginineM S Mulligan, J S Warren, C W Smith, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Clinical Immunology (Orlando, Fla.)|April 29, 1999
Effects of immune complex formation and complement activation on circulating platelets in the primateD J Birmingham, L A Hebert, X P Shen, et al.
Transplantation|June 27, 2000
A recombinant soluble chimeric complement inhibitor composed of human CD46 and CD55 reduces acute cardiac tissue injury in models of pig-to-human heart transplantationT J Kroshus, C T Salerno, C G Yeh, et al.
Ophthalmology. Retina|May 4, 2019
Cost Savings Analysis for a Diabetic Retinopathy Teleretinal Screening Program Using an Activity-Based Costing ApproachRobert B Garoon, Weijie V Lin, Alex K Young, et al.
Transplantation|November 11, 1991
The effect of soluble complement receptor type 1 on hyperacute xenograft rejectionS K Pruitt, W M Baldwin, H C Marsh, et al.
Journal of the American Society of Nephrology : JASN|May 1, 1995
The effects of soluble recombinant complement receptor 1 on complement-mediated experimental glomerulonephritisW G Couser, R J Johnson, B A Young, et al.
Pharmacological Research|September 1, 2001
Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitorC Qian, S B Hwang, L Libertine-Garahan, et al.
Drug and Alcohol Dependence|August 26, 2022
Kratom use categories and their associations with co-occurring substance use and mental health disorder symptoms during the COVID-19 pandemicDavid Adzrago, Elizabeth O Obekpa, Tiffany A Suragh, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 1, 1992
Role of complement in endotoxin/platelet-activating factor-induced lung injuryR Rabinovici, C G Yeh, L M Hillegass, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 12, 2024
Healthcare Costs in the United States by Demographic Characteristics and Comorbidity StatusNaomi N Adjei, Allen Haas, Charlotte C Sun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1992
Lung injury after deposition of IgA immune complexes. Requirements for CD18 and L-arginineM S Mulligan, J S Warren, C W Smith, et al.
Pageof 5